
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
According to a recent report from the Japanese Ministry of Health and Welfare, the mortality rate for hepatocellular carcinoma (HCC) is more than 30 per 100000 pop ulation. In addition,epidemiologists predictan increase in this figure by the year 2015, because of the rather high incidence of chronic liver diseases caused by HCY. The same situation has been observed in other Asian countries. It seems that HCC is likely to be an endemic disease, because of the higher preva lence of chronic hepatitis and liver cirrhosis caused by HBV, HCV, and/or aflatoxins in Asian and African countries. We also note that an interesting paper appeared in a recent issue of the New England Journal of Medicine describing the increase in younger HCC patients in the United States as compared with past decades. At present, silent hepatitis C infection is now smoldering in 4 million mostly unsuspecting Americans. Those carriers will be candidates for chronic liver disease, which is a pre disposing factor for the development of HCC. In Europe there are an estimated 5 million carriers. Accordingly, it is important to do all we can to reduce the prevalence of HCC not only in African and Asian countries, but also in the United States and Europe. With this perspective,last year the Japanese Society for Hepatology, in cooperation with the Ministry of Health and Welfare, initiated a national campaign to fight HCC.
This book addresses the growing global challenge of hepatocellular carcinoma (HCC), a disease with a significant and increasing mortality rate, particularly in Asian and African countries, but also showing concerning trends in the United States and Europe. The text highlights the role of chronic liver diseases, such as those caused by HBV, HCV, and aflatoxins, as major predisposing factors for HCC. It notes the predicted rise in mortality rates and the increasing incidence among younger populations, underscoring the urgent need for comprehensive strategies to combat this prevalent disease.
This work appears to be a focused collection of research and epidemiological data concerning hepatocellular carcinoma, likely intended for medical professionals and public health officials. The provided description emphasizes the disease's prevalence, its contributing factors, and the global efforts to combat it, suggesting a comprehensive overview of the current state of knowledge and intervention strategies. The text points to the critical need for continued research and public health action to mitigate the impact of HCC.
Page Count:
107
Publication Date:
2012-02-05
Publisher:
Springer Japan
ISBN-10:
4431679146
ISBN-13:
9784431679141
No comments yet. Be the first to share your thoughts!